Seagen announced positive topline results from the pivotal Phase II MOUNTAINEER clinical trial investigating TUKYSA® (tucatinib)…
dcorriganMay 27, 2022
Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in…
dcorriganMay 25, 2022
Alpine Immune Sciences, a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer…
dcorriganMay 25, 2022
Since 2013, Dr. Leo Stamatatos has been developing a different kind of HIV vaccine intended…
dcorriganMay 24, 2022
Building on momentum from the highly successful COVID-19 vaccine clinical trials, the HIV Vaccine Trials Network (HVTN)…
dcorriganMay 20, 2022
Neoleukin, a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, announced…
dcorriganMay 19, 2022
Studies in the lab of Steven F. Ziegler, PhD, at Benaroya Research Institute (BRI) found that…
dcorriganMay 19, 2022
Imagine if there were drugs that could optimize their dose in real-time, leading to better…
dcorriganMay 19, 2022
It’s become a cliché: “They are wise beyond their years.” Unless you’re referring to Debora…
dcorriganMay 18, 2022
